Zucker Hillside Hospital Ranked Among Top 60 Cancer Centers
Locales: New York, UNITED STATES

ROCKVILLE CENTRE, NY - March 9th, 2026 - The Northwell Health Cancer Institute at Zucker Hillside Hospital has cemented its position as a leading national center for pancreatic cancer treatment, being named among the top 60 facilities in the United States by Castle Connolly. This recognition, announced today, underscores a growing trend of specialized cancer care excellence within the Northwell Health system and offers hope to patients facing one of the most challenging cancers to treat.
Castle Connolly's annual ranking is highly respected within the medical community, relying on a rigorous methodology that incorporates peer nominations from physicians, verified patient reviews, and a comprehensive analysis of hospital data. This isn't simply a popularity contest; it's an indication that doctors across the country recognize Zucker Hillside Hospital's commitment to both clinical expertise and patient-centered care.
"We're incredibly proud of this recognition," stated Dr. Richard Katowitz, medical director of the Northwell Health Cancer Institute at Zucker Hillside Hospital. "It validates the expertise and dedication of our multidisciplinary team and reinforces our commitment to providing comprehensive, innovative care for patients with pancreatic cancer." Dr. Katowitz emphasized that the ranking wasn't just about individual skill, but the synergistic effect of a team working cohesively to provide the best possible outcomes for their patients.
The Growing Challenge of Pancreatic Cancer
Pancreatic cancer remains a particularly aggressive and difficult-to-detect cancer. Often diagnosed at late stages when treatment options are limited, the five-year survival rate is still relatively low compared to other cancer types. This makes advancements in early detection, surgical techniques, and medical therapies crucial. The importance of specialized centers like Zucker Hillside, capable of delivering a full spectrum of care, cannot be overstated.
A Multidisciplinary Approach: The Key to Success
The success of Zucker Hillside's program isn't accidental. The hospital has intentionally built a highly collaborative, multidisciplinary team. This includes not only the expected surgical, medical, and radiation oncologists, but also crucial support staff like gastroenterologists, pathologists, radiologists, nutritionists, and palliative care specialists. This holistic approach means that every aspect of a patient's care - from diagnosis and treatment to symptom management and emotional support - is thoughtfully addressed.
This integrated team meets regularly to discuss each patient's case, ensuring that treatment plans are tailored to the individual's specific needs and disease characteristics. Recent advancements in genomic sequencing allow for personalized medicine approaches, identifying biomarkers that can predict treatment response and guide therapeutic decisions. Zucker Hillside has been a leader in integrating these technologies into its pancreatic cancer program.
Beyond Standard Treatment: Clinical Trials and Innovation
The hospital's commitment extends beyond established protocols. Zucker Hillside actively participates in national and international clinical trials, offering patients access to cutting-edge therapies that may not be available elsewhere. This dedication to innovation is vital in a field where new treatment strategies are constantly evolving. The ongoing clinical trials focus on novel immunotherapies, targeted therapies, and improved surgical techniques, providing hope for more effective treatments in the future.
State-of-the-Art Diagnostics and Comprehensive Support
Zucker Hillside's pancreatic cancer program boasts state-of-the-art diagnostic capabilities, including advanced imaging techniques and endoscopic procedures. Early and accurate diagnosis is critical, and the hospital's investment in these technologies allows for precise staging and monitoring of the disease. Furthermore, recognizing the significant physical and emotional toll cancer treatment takes, the hospital provides comprehensive support services, including nutritional counseling, psychological support, and pain management.
Looking Ahead: The Future of Pancreatic Cancer Care
This recognition from Castle Connolly serves as a springboard for continued growth and innovation. Northwell Health is investing heavily in cancer research and expanding its network of specialized cancer centers throughout the region. The goal is to provide access to world-class care for all patients, regardless of their location. The future of pancreatic cancer care will likely involve even more personalized treatments, earlier detection methods, and a greater emphasis on preventative strategies. Zucker Hillside Hospital is poised to be at the forefront of these advancements, continuing to improve the lives of patients battling this devastating disease.
Read the Full Patch Article at:
[ https://patch.com/new-york/rockvillecentre/li-hospital-makes-top-60-pancreatic-cancer-facilities-u-s ]